Outro Raises $7M in Funding

Outro, a New York-based healthcare company focused on helping patients discontinue psychiatric medications, has raised $7 million in combined pre-seed and seed financing. The company provides a specialized deprescribing platform designed to assist patients in safely tapering off medications, with an initial focus on antidepressants.

Investors

The funding rounds included participation from Listen Ventures, Cake Ventures, Jason Calacanis’s LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group, Pave Health Ventures, and additional investors.

Outro Use of Funds

Outro plans to use the capital to expand its deprescribing platform into additional medication categories beyond antidepressants. The company will also focus on growing its network of specialized clinicians, developing AI-supported workflows for clinical and administrative tasks, and fostering partnerships with universities and patient advocacy organizations.

About Outro

Founded by Brandon Goode and Dr. Mark Horowitz, Outro aims to bridge the gap in mental healthcare by providing a structured, evidence-informed approach to medication discontinuation. The company offers an integrated network that combines trained clinicians, tapering protocols, and patient monitoring software to help individuals safely stop medications.

Funding Details

Company Website: https://outro.com

Company: Outro
Raised: $7M
Round: Pre-seed, Seed
Funding Date: October 8, 2026
Additional Investors: Listen Ventures, Cake Ventures, LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group, Pave Health Ventures
Software Category: Healthcare Technology
Source: https://pulse2.com/outro-raises-7-million/